This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
The dopamine hypothesis of bipolar affective disorder: the state of the art and implications for treatment
Molecular Psychiatry Open Access 14 March 2017
-
Genetic deletion of fibroblast growth factor 14 recapitulates phenotypic alterations underlying cognitive impairment associated with schizophrenia
Translational Psychiatry Open Access 10 May 2016
-
Search for common targets of lithium and valproic acid identifies novel epigenetic effects of lithium on the rat leptin receptor gene
Translational Psychiatry Open Access 14 July 2015
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Knable, M., Barci, B., Webster, M. et al. Molecular abnormalities of the hippocampus in severe psychiatric illness: postmortem findings from the Stanley Neuropathology Consortium. Mol Psychiatry 9, 544 (2004). https://doi.org/10.1038/sj.mp.4001527
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.mp.4001527
This article is cited by
-
The dopamine hypothesis of bipolar affective disorder: the state of the art and implications for treatment
Molecular Psychiatry (2017)
-
Genetic deletion of fibroblast growth factor 14 recapitulates phenotypic alterations underlying cognitive impairment associated with schizophrenia
Translational Psychiatry (2016)
-
Search for common targets of lithium and valproic acid identifies novel epigenetic effects of lithium on the rat leptin receptor gene
Translational Psychiatry (2015)
-
NACP-Rep1 relates to Beck Depression Inventory Scores in Healthy Humans
Journal of Molecular Neuroscience (2011)
-
Abnormal Glutamate Receptor Expression in the Medial Temporal Lobe in Schizophrenia and Mood Disorders
Neuropsychopharmacology (2007)